PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsventricular fibrillation
MeSH D014693 - ventricular fibrillation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001145:Cardiac arrhythmias
$
Success rate
D014693: 
Ventricular fibrillation
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmiodarone Amiodarone  1998-11-30   
Lidocaine, Prilocaine Emla  1992-12-30   
Epinephrine Epinephrine  2018-08-16   
Lidocaine Lidocaine  2018-01-16   
Metoprolol Metoprolol  1994-09-30   
Mexiletine Mexiletine  1995-05-16   
Propranolol Propranolol  1987-10-07   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-12-01   
Sotalol Sotalol  2000-05-01   
Novast LaboratoriesMetoprolol Metoprolol  2018-02-06   
Mexiletine Mexiletine  2021-01-25   
PadagisLidocaine, Prilocaine Lidocaine Prilocaine  2021-07-27   
Taro PharmaceuticalAmiodarone Amiodarone  2001-03-30   
Lidocaine Lidocaine  1982-01-01   
Lidocaine, Tetracaine Pliaglis 2031-01-14 2006-06-29   
Glenmark PharmaceuticalsLidocaine Lidocaine  2016-09-09   
MylanAmiodarone Amiodarone  1999-02-24   
Lidocaine Lidocaine  2015-08-07   
Metoprolol tartrate, Metoprolol Metoprolol  1993-12-21   
Hydrochlorothiazide, Metoprolol Metoprolol Hydrochlorothiazide  2004-08-20   
Propranolol Propranolol  1985-11-19   
ViatrisEpinephrine Epi 2025-09-11 1987-12-22   
Rising PharmaceuticalsLidocaine Lidocaine  2010-09-27   
Propranolol hydrochloride Propranolol  2007-02-15   
Sotalol Sotalol  2000-12-19   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-03-04   
Mexiletine Mexiletine  2022-08-26   
RocheCeftriaxone, Lidocaine Rocephin  1984-12-21 $261.076 M Y2021 
Armstrong PharmaceuticalsEpinephrine Epinephrine  1984-05-23   
Epinephrine Primatene Mist 2026-01-26 2018-11-07   
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
33%
1/3
Phase 3
74%
17/23
Approved: 13Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
12
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use